Senator Panfilo Lacson expressed suspicion of an attempt to overprice Sinovac COVID-19 vaccines in the Philippines, noting a significant price difference compared to other countries.
He questioned the initial reported price of P3,629.50 for two doses of Sinovac in the Philippines, which he calculated could amount to billions of pesos.
While the Department of Health confirmed the price may have been reduced to P650 per dose, Lacson emphasized the need to stick to facts and logical suspicions of corruption in cases of overpricing.
The Philippines has secured 25 million doses of Sinovac, with initial deliveries expected, though the vaccine has not yet been approved by health regulators.
Lacson also pointed out Sinovac's history of alleged bribery and questioned why the deal was not a government-to-government transaction.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.


